Charles M. Cohen
Director/Board Member at Sirion Holdings, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michael Morrissey | M | 63 | 24 years | |
| Barry S. Butler | M | - |
Sirion Holdings, Inc.
 Sirion Holdings, Inc. BiotechnologyHealth Technology Sirion Holdings, Inc. provides pharmaceutical products and medical devices for the ophthalmic market. It offers contract services, which includes clinical, regulatory, consulting, and medical education services. The company was founded by Susan K. Benton, Barry S. Butler, Philippe Boulangeat, and Vogel Roger in 2005 and is headquartered in Tampa, FL. | 19 years |
| Alan Garber | M | 68 | 19 years | |
| Susan T. Hubbard | F | - | 8 years | |
| Julie Smith | F | 53 | 8 years | |
| William F. Stringer | M | - |
Sirion Holdings, Inc.
Sirion Holdings, Inc. BiotechnologyHealth Technology Sirion Holdings, Inc. provides pharmaceutical products and medical devices for the ophthalmic market. It offers contract services, which includes clinical, regulatory, consulting, and medical education services. The company was founded by Susan K. Benton, Barry S. Butler, Philippe Boulangeat, and Vogel Roger in 2005 and is headquartered in Tampa, FL. | - |
| Philippe Boulangeat | M | - |
Sirion Holdings, Inc.
Sirion Holdings, Inc. BiotechnologyHealth Technology Sirion Holdings, Inc. provides pharmaceutical products and medical devices for the ophthalmic market. It offers contract services, which includes clinical, regulatory, consulting, and medical education services. The company was founded by Susan K. Benton, Barry S. Butler, Philippe Boulangeat, and Vogel Roger in 2005 and is headquartered in Tampa, FL. | - |
| Susan Benton | F | 59 |
Sirion Holdings, Inc.
Sirion Holdings, Inc. BiotechnologyHealth Technology Sirion Holdings, Inc. provides pharmaceutical products and medical devices for the ophthalmic market. It offers contract services, which includes clinical, regulatory, consulting, and medical education services. The company was founded by Susan K. Benton, Barry S. Butler, Philippe Boulangeat, and Vogel Roger in 2005 and is headquartered in Tampa, FL. | - |
| Jeffrey Hessekiel | M | 55 | 10 years | |
| Jacqueline Wright | F | 64 | 3 years | |
| Maria Freire | M | 69 | 6 years | |
| Patrick Haley | M | 48 | 14 years | |
| George Poste | M | 79 | 20 years | |
| Jack Wyszomierski | M | 68 | 20 years | |
| Peter Lamb | M | 63 | 24 years | |
| Dana Aftab | M | - | 26 years | |
| Christopher Senner | M | 56 | 9 years | |
| C. Christine Miller | M | - |
Sirion Holdings, Inc.
Sirion Holdings, Inc. BiotechnologyHealth Technology Sirion Holdings, Inc. provides pharmaceutical products and medical devices for the ophthalmic market. It offers contract services, which includes clinical, regulatory, consulting, and medical education services. The company was founded by Susan K. Benton, Barry S. Butler, Philippe Boulangeat, and Vogel Roger in 2005 and is headquartered in Tampa, FL. | - |
| Laura Dillard | F | - | 19 years | |
| Liza Page Nelson | F | 64 |
Sirion Holdings, Inc.
Sirion Holdings, Inc. BiotechnologyHealth Technology Sirion Holdings, Inc. provides pharmaceutical products and medical devices for the ophthalmic market. It offers contract services, which includes clinical, regulatory, consulting, and medical education services. The company was founded by Susan K. Benton, Barry S. Butler, Philippe Boulangeat, and Vogel Roger in 2005 and is headquartered in Tampa, FL. | - |
| Kevin Kinsella | M | 78 |
Sirion Holdings, Inc.
Sirion Holdings, Inc. BiotechnologyHealth Technology Sirion Holdings, Inc. provides pharmaceutical products and medical devices for the ophthalmic market. It offers contract services, which includes clinical, regulatory, consulting, and medical education services. The company was founded by Susan K. Benton, Barry S. Butler, Philippe Boulangeat, and Vogel Roger in 2005 and is headquartered in Tampa, FL. | 18 years |
| Thomas M. Riedhammer | M | 76 |
Sirion Holdings, Inc.
Sirion Holdings, Inc. BiotechnologyHealth Technology Sirion Holdings, Inc. provides pharmaceutical products and medical devices for the ophthalmic market. It offers contract services, which includes clinical, regulatory, consulting, and medical education services. The company was founded by Susan K. Benton, Barry S. Butler, Philippe Boulangeat, and Vogel Roger in 2005 and is headquartered in Tampa, FL. | - |
| Stefan Krauss | M | - | 8 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jason S. Fisherman | M | 67 |
Synthesis Capital
 Synthesis Capital Investment ManagersFinance Synthesis Capital is a venture capital firm founded in 2007. The firm is headquartered in Boston, Massachusetts. | 11 years |
| George Scangos | M | 76 |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | 24 years |
| Stephen Worland | M | 66 |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | 10 years |
| Geoff Duyk | M | 64 | 7 years | |
| Peter T. Slover | M | 49 |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | 8 years |
| Michael Tarnow | M | 79 |
Creative Biomolecules, Inc.
 Creative Biomolecules, Inc. BiotechnologyHealth Technology Creative Biomolecules, Inc. develops products for human tissue regeneration and organs based on morphogenic proteins. The company was founded by Roberto Crea, Fred Bernard Craves and Charles Cohen and is headquartered in Hopkinton, MA. | 5 years |
| Thomas E. Needham | M | 60 |
Synthesis Capital
Synthesis Capital Investment ManagersFinance Synthesis Capital is a venture capital firm founded in 2007. The firm is headquartered in Boston, Massachusetts. | - |
| Vincent Marchesi | M | 88 | 22 years | |
| Lance Willsey | M | 62 | 26 years | |
| Glen Y. Sato | M | 65 | 4 years | |
| Deborah Burke | F | - | - | |
| William Waddill | M | 67 | 4 years | |
| Carl Feldbaum | M | 80 | 16 years | |
| Christoph Pereira | M | 51 | 3 years | |
| Elizabeth Reed | F | 53 |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | 11 years |
| Marios Fotiadis | M | 51 |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | 9 years |
| Francis McCormick | M | 73 | 11 years | |
| James B. Bucher | M | 59 | 7 years | |
| Jennifer Drimmer | F | - | 14 years | |
| Pamela A. Simonton | F | 74 | - | |
| Oleg Neroslavsky | M | - |
Painewebber Group, Inc.
| 7 years |
| Yifan Zhai | M | 62 | 2 years | |
| Sharon Cload | M | - |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | 4 years |
| Camille DeLuca-Flaherty | M | - | - | |
| Jeff P. Coon | M | 61 | 1 years | |
| Patricia J. Oto | F | - |
Anesiva, Inc.
 Anesiva, Inc. Pharmaceuticals: MajorHealth Technology Anesiva, Inc. develops and markets therapeutic drugs. Anesiva is a biopharmaceutical company focused on the development and commercialization of novel pharmaceutical products for pain management. The firm was founded in 1999 and is headquartered in San Francisco, CA. | 5 years |
| Anil Dasu | M | 60 |
Anesiva, Inc.
Anesiva, Inc. Pharmaceuticals: MajorHealth Technology Anesiva, Inc. develops and markets therapeutic drugs. Anesiva is a biopharmaceutical company focused on the development and commercialization of novel pharmaceutical products for pain management. The firm was founded in 1999 and is headquartered in San Francisco, CA. | 2 years |
| S. Michael Imperiale | M | - | 2 years | |
| Carmine Stengone | M | 48 |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | 2 years |
| Remi Barbier | M | 64 | 2 years | |
| David Matthews | M | - | - | |
| Ross Bartfield | M | - |
Painewebber Group, Inc.
| 5 years |
| David Pollak | M | - |
Painewebber Group, Inc.
| 5 years |
| F. Michael Yakes | M | - | 11 years | |
| Anne Champsaur | M | - | - | |
| Rekha Hemrajani | F | 54 | 8 years | |
| Kanya Rajangam | M | 50 | 3 years | |
| William Berg | M | - | - | |
| Jonathan Berndt | M | - | - | |
| Gregg Bernier | M | - | - | |
| Natalie Sacks | M | 59 | 2 years | |
| Qin Hua Ru | M | - | 1 years | |
| Wally Reiher | M | - | 12 years | |
| Vicki Goodman | M | 55 | 1 years | |
| Kin Hung Yu | M | 61 |
Anesiva, Inc.
Anesiva, Inc. Pharmaceuticals: MajorHealth Technology Anesiva, Inc. develops and markets therapeutic drugs. Anesiva is a biopharmaceutical company focused on the development and commercialization of novel pharmaceutical products for pain management. The firm was founded in 1999 and is headquartered in San Francisco, CA. | - |
| Jason Whitt | M | - |
Painewebber Group, Inc.
| 1 years |
| Arthur P. DeCillis | M | 68 | 8 years | |
| Mark Douglas Altman | M | - |
Painewebber Group, Inc.
| - |
| Steven James | M | 66 | 1 years | |
| Najafi Behrooz | M | - | 7 years | |
| Leone Patterson | F | 61 | 3 years | |
| Kristine Ball | M | 52 | 5 years | |
| Frank Karbe | M | 55 | 10 years | |
| Mary Yaroshevsky-Glanville | F | 59 |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | 8 years |
| Kimberly Manhard | F | 64 | 1 years | |
| J. Garland | M | 55 | 3 years | |
| Steven Holtzman | M | 70 |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | 7 years |
| Gisela Schwab | M | 67 | 5 years | |
| Donald Baird Marron | M | 88 |
Painewebber Group, Inc.
| 19 years |
| Gary Alexander Friedle | M | - |
Painewebber Group, Inc.
| 10 years |
| John Henry Peterson | M | - |
Painewebber Group, Inc.
| 2 years |
| Keith Andrew Mills | M | - |
Painewebber Group, Inc.
| 4 years |
| Andrew Peters | M | - | - | |
| Ronald J. Barone | M | - |
Painewebber Group, Inc.
| 5 years |
| Angela Larson | F | - |
Painewebber Group, Inc.
| 3 years |
| Michael A. Hecht | M | - |
Painewebber Group, Inc.
| 3 years |
| Mark David Coe | M | - |
Painewebber Group, Inc.
| 4 years |
| Deepak Khanna | M | - |
Painewebber Group, Inc.
| 4 years |
| Claire M. Gallacher | F | - |
Painewebber Group, Inc.
| - |
| Michael D. Bluestein | M | - |
Painewebber Group, Inc.
| - |
| Jane M. Green | M | - | - | |
| Joseph Bratica | M | 60 |
Creative Biomolecules, Inc.
Creative Biomolecules, Inc. BiotechnologyHealth Technology Creative Biomolecules, Inc. develops products for human tissue regeneration and organs based on morphogenic proteins. The company was founded by Roberto Crea, Fred Bernard Craves and Charles Cohen and is headquartered in Hopkinton, MA. | 2 years |
| Stephen Doberstein | M | 65 | 3 years | |
| Casey C. Kopczynski | M | 62 | 6 years | |
| Mike Willis | M | - |
Painewebber Group, Inc.
| 3 years |
| Angie You | M | 51 | - | |
| Richard Tsai | M | - | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
| Germany | 0 | -.--% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Charles M. Cohen
- Personal Network
